Prognostic value of using FeNO to guide step-down treatment decisions in asthma

K. Wang (Oxford, United Kingdom), J. Verbakel (Oxford, United Kingdom), A. Fleming-Nouri (Oxford, United Kingdom), J. Brewin (Oxford, United Kingdom), J. Oke (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), M. Thomas (Southampton, United Kingdom)

Source: International Congress 2018 – Biomarkers for evaluating asthma
Session: Biomarkers for evaluating asthma
Session type: Thematic Poster
Number: 1097
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Wang (Oxford, United Kingdom), J. Verbakel (Oxford, United Kingdom), A. Fleming-Nouri (Oxford, United Kingdom), J. Brewin (Oxford, United Kingdom), J. Oke (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), M. Thomas (Southampton, United Kingdom). Prognostic value of using FeNO to guide step-down treatment decisions in asthma. 1097

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: